Oxy Watchdog

Keeping An Eye On OxyContin

Posts Tagged ‘opioid’

Opiate drug use in workplace nearly doubles

Posted by Oxy Watchdog on October 28, 2010

Use of opiate drugs in the workplace, such as OxyContin, has increased by 40 percent from 2005 to 2009 , according to data from Quest Diagnostics, a diagnostic testing company. This article in the New York Times reports that while working while under the influence can pose safety risks, many employees may be taking legal pain medications prescribed by doctors, and impairment can be difficult to prove. Last year alone, the rate of employees testing positive for prescription drugs rose by 18 percent, mirroring similar trends of rising prescription drug use in the U.S. population overall.

Read about prescription drug abuse trends in the U.S. here.

Advertisements

Posted in Pain Advocates, Surveys & Statistics, Trends | Tagged: , , , , , , , , , , , , , | Leave a Comment »

New brand of prescription painkiller oxycodone approved

Posted by Oxy Watchdog on October 23, 2010

A new form of oxycodone hydrochloride, a synthetic opiate like the brand name drug OxyContin, was approved by the U.S. Food and Drug Administration this week, reports this release from the FDA. Lehigh Valley Technologies formulated the brand-name Oxycodone HCI as a morphine-derived painkiller to rival Purdue Pharma’s best-selling brand OxyContin. Purdue has tried to limit production of time-release and generic brands of oxycodone and has been embroiled in several lawsuits to maintain control of its $3 billion-per-year drug. According to its website, Lehigh Valley has developed its own version of abuse-deterrent drugs. In 2009, Lehigh Valley received a warning from the FDA for marketing an unapproved version of morphine, as detailed in this letter from the FDA. Like the brand-name OxyContin, Oxycodone HCI is a Schedule II narcotic and highly prone to addiction.

Read more about Purdue’s suppression of generic forms of oxycodone here.

Posted in Pharmaceutical Industry | Tagged: , , , , , , , , , , , , , , , , , | Leave a Comment »

Makers of Oxy contribute to prescription monitoring programs

Posted by Oxy Watchdog on October 22, 2010

Purdue Pharma, makers of OxyContin, contributed $200,000 towards the support and implementation of prescription drug monitoring programs earlier this week, according to this article from News-Medical.net. The monies were contributed to the non-profit National Association of State Controlled Substances Authorities and will go toward grants which assist states to maintain prescription monitoring programs, the Association’s main focus. In the article, a Purdue representative states that the pharmaceutical company has been supporting appropriately-designed monitoring programs to help reduce the abuse and diversion of prescription drugs. According to the article, the Association will manage the funding of grants and Purdue will have no input in the final selection process. Though OxyContin abuse has skyrocketed in the U.S. and abroad, Purdue Pharma makes a reported $3 billion per year on the opiate painkiller.

Read more about prescription monitoring programs here.

Posted in Pharmaceutical Industry | Tagged: , , , , , , , , , , , , , , | 1 Comment »

Heroin use increases in Utah, abusers younger than ever

Posted by Oxy Watchdog on October 21, 2010

As abuse of heroin in Utah climbs upward, authorities are finding the age of users is going down, sometimes as young as 13 or 14 years old, reports this article on ksl.com. Though OxyContin and marijuana tend to be more popular among youths, the costly price drives them to a less expensive alternative. The fact that the dealers have become extremely sophisticated – often making heroin easier to obtain than cigarettes or alcohol for teens – makes the problem more prevalent. Though the cost of heroin is cheaper for users in the Salt Lake City area, the average age of whom is 16 to 23, the cost can be far more deadly since the drug is now 60 percent pure, whereas in the 1970s it was only three percent pure.

Read about the Oxy-to-heroin trend among teens here.

Posted in Crime, Trends | Tagged: , , , , , , , , , | Leave a Comment »

New drug for Oxy, heroin addiction approved by FDA

Posted by Oxy Watchdog on October 18, 2010

A new treatment for opioid addiction – which includes heroin and painkillers like OxyContin and Vicodin – was approved by the U.S. Food and Drug Administration earlier this week, according to this article in USA Today. Unlike existing treatments which are essentially low-dose versions of the drug, Vivitrol is a once-monthly injection that blocks the effects of opiate drugs and is non-addictive. Though Vivitrol will sell for about $1,100 per injection, the creators are developing an implant that will last for six months, reports this article in the Washington Post. The article also cites a study by the National Institute on Drug Abuse which found that about 810,000 Americans are addicted to heroin and another 1.85 million to opioid painkillers such as OxyContin.

Read about the drug buprenorphine used in opioid addiction treatment here.

Posted in Informational, Pharmaceutical Industry, Policy & Regulation, Trends | Tagged: , , , , , , , , , , , , , | Leave a Comment »

 
%d bloggers like this: